Angela Loyse

Also affiliated with The George Institute for Global Health, Université Paris Cité, Institut de Myologie

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial”.

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial

The Lancet Global Health(2022)10.1016/s2214-109x(22)00450-8

N/A

1.2DataRank · unranked

31 citations

Charles Muthoga, David B Meya, Lillian Tugume, Darlisha Williams, Radha Rajasingham +160 more

Cryptococcal meningoencephalitis: time for action

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(20)30771-4

N/A

0.609DataRank · unranked

57 citations

Angela Loyse, Joe N Jarvis, Melanie Alufandika, Thomas S. Harrison, Henry C. Mwandumba +6 more

Ending deaths from HIV-related cryptococcal meningitis by 2030

The Lancet Infectious Diseases(2020)10.1016/s1473-3099(20)30909-9

N/A

0.505DataRank · unranked

28 citations

Tom Chiller, Alex Jordan, David W. Denning, Thomas S. Harrison, Nelesh P. Govender +8 more

Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa

Clinical Infectious Diseases(2019)10.1093/cid/ciy971

N/A

0.489DataRank · unranked

25 citations

Lawrence Mwenge, Shabir Lakhi, Duncan Chanda, Peter Mwaba, Síle F Molloy +16 more

Target product profile and discovery and development path for novel cryptococcal disease treatments

Journal of Infection(2025)10.1016/j.jinf.2025.106643

N/A

0.104DataRank · unranked

1 citations

Manu De Rycker, Ian H. Gilbert, William Hope, Justine Jelagat Odionyi, Michael Keegan +7 more

Resolving the CD4-testing crisis to help end AIDS-related deaths

The Lancet Global Health(2024)10.1016/s2214-109x(24)00444-3

N/A

0DataRank · unranked

12 citations

Rita Oladele, Tinne Gils, Radha Rajasingham, Jonathan Falconer, Pamela Achii +9 more

Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial

Trials(2026)10.1186/s13063-026-09520-x

N/A

0DataRank · unranked

0 citations

Jeremy S. Nel, Mahomed-Yunus Moosa, Douglas P. Wilson, Merika Tsitsi, Sayoki Mfinanga +23 more

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab397

N/A

0DataRank · unranked

14 citations

Jayne Ellis, Cecilia Kanyama, Charles Kuoanfank, Elvis Temfack, Sayoki Mfinanga +16 more